COBICISTAT
| Brand name | TYBOST |
|---|---|
| Active ingredient | COBICISTAT |
| Strength | 90MG |
| Dosage form | TABLET |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | June 2025 |
| Marketing status | DISCN |
| Patent | Expires | Type |
|---|---|---|
| 10039718*PED | April 2033 | — |
| 10039718 | October 2032 | product |
| 8148374*PED | March 2030 | — |
| 8148374 | September 2029 | substance, product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.